In the specialized field of immunology and neuroscience research, the study of Myelin Oligodendrocyte Glycoprotein (MOG) remains a cornerstone for understanding central nervous system (CNS) dynamics. MOG Antibody Disease - Symptoms, Causes, Treatment As an enthusiast who follows the latest developments in peptide synthesis and laboratory applications, I have observed a growing interest in the specific utility of 3 MOG peptides and their variants in experimental models.
Defining the Entity: MOG and its Peptide Fragments
Myelin oligodendrocyte glycoprotein (MOG) is a critical membrane protein found exclusively within the CNS, localized on the surface of myelin sheaths and oligodendrocyte cytoplasmic membranes. From a technical standpoint, the MOG protein is a single, non-glycosylated polypeptide chain. When researchers discuss MOG peptide fragments, they are typically referring to specific immunodominant epitopes used to stimulate antigen-specific T cell responses.
The most frequently studied fragment is the MOG Protein 35-55. This sequence is widely recognized as a key peptide for inducing experimental autoimmune encephalomyelitis (EAE) in rodent models. By utilizing high-purity MOG 35-55 peptide, labs can reliably create controlled environments to observe immunological pathways.
Key Variations and Structural Significance
When sourcing these compounds, one often encounters MOG 35-55 human sequences (MEVGWYRPPFSRVVHLYRNGK) and their murine counterparts. The differentiation between these is vital for experimental accuracy. Furthermore, researchers are now exploring single β3-amino acid substitutions to MOG peptides to investigate how structural modifications alter binding affinities and immunogenicity.
I have tracked several developments regarding OM-MOG35–55, which highlights the shift toward personalized antigen research. Whether you are looking to explore high-purity MOG 35–55 peptide for T cell assays or seeking a standardized high-purity MOG (35-55) peptide for academic inquiry, the quality of the synthesis—often verified by a molecular mass of approximately 2582 Dalton—is paramount.
Distinguishing Research Models from Clinical Contexts
It is essential to distinguish between the use of these peptides in a laboratory setting and clinical terminology. While the term MOG antibody disease (MOGAD) or myelin oligodendrocyte glycoprotein antibody-associated disease 03-Jan-2024—Myelin oligodendrocyte glycoprotein antibody-associated disease, also known as MOGAD, is a rare inflammatory disease that affects the central nervous system.Read more (MOGAD) appears frequently in literature regarding inflammatory demyelinating conditions, these are clinical diagnostic categories.
From a research perspective, Myelin oligodendrocyte glycoprotein (MOG) peptide (35-55) is strictly a tool for scientific modeling. When we discuss 3 MOG fragments or specific analogs, we are analyzing the biochemical interactions of these sequences as antigens MOG (35-55) - CNS Myelin Peptide for Neuroscience , not providing guidance for human health. The focus remains on the structural biology of the Myelin Oligodendrocyte Glycoprotein and its role MOG (35-55) - CNS Myelin Peptide for Neuroscience in basic cellular research.
Why Quality Matters in Peptide Res Myelin Oligodendrocyte Glycoprotein (MOG) (35-55) (human) earch
For those invol by RF Frausto·2007·Cited by 34—Herein we analyzedthree separate MOG peptidesfor their propensity to induce EAE in wildtype mice and immunoproteasome-deficient mice, and we evaluated the Read more ved in procurement for research facilities, the integrity of the MOG peptide is non-negotiable. Whether you are ordering a standard MOG 35-55 or a specialized variant, ensure the supplier provides docum MOG myelin oligodendrocyte glycoprotein [ (human)] entation on purity levels and sequence verification.
The study of Myelin oligodendrocyte glycoprotein (MOG) continues to evolve. By focusing on the precise application of these specific peptide chains, the scientific community gains deeper insights into the complex architecture of the CNS. Always prioritize suppliers who demonstrate transparency regarding the synthesis of MOG 35-55 human and other related Myelin oligodendrocyte glycoprotein MOG (35-55) fragments to ensure your experimental data remains robust and reproducible.